B cells are required for tumor-targeting Salmonella in host

被引:30
|
作者
Lee, Che-Hsin [1 ]
Hsieh, Jeng-Long [2 ]
Wu, Chao-Liang [3 ]
Hsu, Hui-Chun [4 ]
Shiau, Ai-Li [5 ]
机构
[1] China Med Univ, Dept Microbiol, Sch Med, Taichung 40402, Taiwan
[2] Chung Hwa Univ Med Technol, Dept Nursing, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan 70101, Taiwan
[4] Chang Gung Inst Technol, Ctr Gen Educ, Tao Yuan, Taiwan
[5] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 70101, Taiwan
关键词
B cell; Salmonella; Tumor targeting; Natural antibody; DEFICIENT MICE; TYPHIMURIUM; ANTIBODY; CHOLERAESUIS; RESPONSES; VIRULENT; BACTERIA;
D O I
10.1007/s00253-011-3386-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Systemic administration of Salmonella to tumor-bearing mice leads to the preferential accumulation within tumor sites and retardation of the tumor growth. Host factors including innate and adaptive immune responses influence Salmonella-induced antitumor activity. Antitumor activities of Salmonella are not only determined by the tumor regression but also by the host immune response. Herein, we demonstrated that B cells play an important role in the antitumor activity mediated by Salmonella. Body weight and survival of B cell-deficient mice were decreased compared with wild-type, CD8(+) cell-deficient, or CD4(+) cell-deficient mice after Salmonella administration. Although Salmonella accumulated within the tumors in B cell-deficient mice, the bacterial loads of healthy organs were higher than those in wild-type mice. The inflammation cytokine and bacteremia were found in B cell-deficient mice after Salmonella treatment. When Salmonella accumulated within the tumor, B cells inhibited the dissemination of Salmonella to other healthy organs. The depletion of host B cells resulted in a noticeably higher total number of Salmonella in the tumor and inhibited tumor growth. Meanwhile, B cell-depletive and B cell-adoptive transfer of serum experiments demonstrated that the natural antibody produced by B cell takes part in the control of Salmonella dissemination in tumor-bearing mice. In this study, we want to address the mechanisms of incorporating host immunoresponse as a way to augment the antitumor activities of Salmonella.
引用
收藏
页码:1251 / 1260
页数:10
相关论文
共 50 条
  • [41] Advances on Tumor-Targeting Delivery of Cytotoxic Proteins
    Asrorov, Akmal M.
    Gu, Zeyun
    Min, Kyoung Ah
    Shin, Meong Cheol
    Huang, Yongzhuo
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (01) : 107 - 118
  • [42] Tumor-targeting drug delivery of chemotherapeutic agents
    Ojima, Iwao
    Pure and Applied Chemistry, 2011, 83 (09): : 1685 - 1698
  • [43] Recent advances in tumor-targeting chemotherapy drugs
    Ojima, Iwao
    CANCER DRUG RESISTANCE, 2021, 4 (04) : 885 - 887
  • [44] Glucosylated polyethylenimine as a tumor-targeting gene carrier
    In -Kyu Park
    Seung -Eun Cook
    You -Kyoung Kim
    Hyun -Woo Kim
    Myung -Haing Cho
    Hwan -Jeong Jeong
    Eun -Mi Kim
    Jae -Woon Nah
    Hee -Seung Born
    Chong -Su Cho
    Archives of Pharmacal Research, 2005, 28 : 1302 - 1310
  • [45] THE ROLE OF LIPOPROTEINS IN THE DELIVERY OF TUMOR-TARGETING PHOTOSENSITIZERS
    JORI, G
    REDDI, E
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1993, 25 (10): : 1369 - 1375
  • [46] Development of Pancreatic tumor-targeting Oncolyic Adenovirus
    Aoki, Kazunori
    Yamamoto, Yuki
    Tagawa, Masatoshi
    CANCER SCIENCE, 2018, 109 : 961 - 961
  • [47] Hyaluronan-modified nanoparticles for tumor-targeting
    Sakurai, Yu
    Harashima, Hideyoshi
    EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (09) : 915 - 936
  • [48] Tumor-targeting peptides from combinatorial libraries
    Liu, Ruiwu
    Li, Xiaocen
    Xiao, Wenwu
    Lam, Kit S.
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 110 : 13 - 37
  • [49] Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
    Sugiura, Grant
    Kuehn, Helen
    Sauter, Max
    Haberkorn, Uwe
    Mier, Walter
    MOLECULES, 2014, 19 (02): : 2135 - 2165
  • [50] Novel tumor-targeting methods show promise
    不详
    ONCOLOGY-NEW YORK, 1998, 12 (09): : 1371 - 1371